000 | 01505 a2200397 4500 | ||
---|---|---|---|
005 | 20250514181232.0 | ||
264 | 0 | _c20040921 | |
008 | 200409s 0 0 eng d | ||
022 | _a1388-9842 | ||
024 | 7 |
_a10.1016/j.ejheart.2003.09.005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBahrmann, Philipp | |
245 | 0 | 0 |
_aPentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms. _h[electronic resource] |
260 |
_bEuropean journal of heart failure _cMar 2004 |
||
300 |
_a195-201 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aCardiomyopathy, Dilated _xblood |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aEchocardiography |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-6 _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xblood |
650 | 0 | 4 |
_aPentoxifylline _xpharmacology |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
700 | 1 | _aHengst, Uta M | |
700 | 1 | _aRichartz, Babara M | |
700 | 1 | _aFigulla, Hans R | |
773 | 0 |
_tEuropean journal of heart failure _gvol. 6 _gno. 2 _gp. 195-201 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejheart.2003.09.005 _zAvailable from publisher's website |
999 |
_c14705925 _d14705925 |